Azitra (AZTR) Tax Provisions (2023 - 2025)

Azitra (AZTR) posted Tax Provisions of $8319.0 for Q4 2025, down 7.88% on a QoQ basis from $9031.0 in Q4 2024, and down 7.88% year-over-year from $9031.0 in Q4 2024.

Azitra (AZTR) Tax Provisions (2023 - 2025) Analysis & Trends

Azitra's Tax Provisions history runs 3 years deep, the most recent figure standing at $8319.0 for Q4 2025.

  • Quarterly Tax Provisions fell 7.88% year-over-year to $8319.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $8319.0 (down 7.88% YoY) and the FY2025 annual result came in at $8319.0, down 7.88% from the prior year.
  • Tax Provisions was $8319.0 for Q4 2025 at Azitra, down from $9031.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $9715.0 in Q1 2023 and bottomed at $7593.0 in Q4 2023.
  • A 3-year average of $8664.5 and a median of $8675.0 in 2024 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2024 — Tax Provisions increased 18.94% — and 2025, when it retreated 7.88%.
  • Azitra's Tax Provisions stood at $7593.0 in 2023, then gained by 18.94% to $9031.0 in 2024, then slipped by 7.88% to $8319.0 in 2025.
  • Business Quant data shows AZTR's Tax Provisions at $8319.0 in Q4 2025, $9031.0 in Q4 2024, and $7593.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Nanobiotix 1,785.82 Bn 1,785.76 Bn - -
2 Akari Therapeutics 979.03 Bn 979.03 Bn - -859,000.00
3 BeOne Medicines 472.98 Bn 468.19 Bn 1.35 Bn 31.86 Mn
4 Vertex Pharmaceuticals 123.73 Bn 116.48 Bn 2.59 Bn 221.50 Mn
5 Regeneron Pharmaceuticals 71.59 Bn 62.84 Bn 3.31 Bn 104.00 Mn
6 Belite Bio 62.00 Bn 62.00 Bn - -
7 Argenx Se 54.67 Bn 49.49 Bn 1.41 Bn 59.00 Mn
8 Alnylam Pharmaceuticals 37.96 Bn 34.95 Bn 959.66 Mn 15.66 Mn
9 Revolution Medicines 36.08 Bn 36.08 Bn - -
10 Azitra 2.07 Mn 2.07 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 8,319.00
Dec 31, 2024 9,031.00
Dec 31, 2023 7,593.00
Mar 31, 2023 9,715.00